Tisbury Pharmaceuticals Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tisbury Pharmaceuticals Inc
Venture Funding Deals: $688.8m In Financings From Avitide To Zai Lab
June venture capital financings for emerging companies totaled more than $688.8m, ranging from an undisclosed round for Avitide to a $120m Series B for Rubius Therapeutics.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.